10-81875828-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001010848.4(NRG3):c.488G>A(p.Arg163Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000412 in 1,456,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001010848.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NRG3 | NM_001010848.4 | c.488G>A | p.Arg163Gln | missense_variant | 1/9 | ENST00000372141.7 | NP_001010848.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NRG3 | ENST00000372141.7 | c.488G>A | p.Arg163Gln | missense_variant | 1/9 | 1 | NM_001010848.4 | ENSP00000361214.2 | ||
NRG3 | ENST00000404547.5 | c.488G>A | p.Arg163Gln | missense_variant | 1/10 | 1 | ENSP00000384796.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000411 AC: 1AN: 243476Hom.: 0 AF XY: 0.00000755 AC XY: 1AN XY: 132460
GnomAD4 exome AF: 0.00000412 AC: 6AN: 1456836Hom.: 0 Cov.: 32 AF XY: 0.00000552 AC XY: 4AN XY: 724958
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 31, 2024 | The c.488G>A (p.R163Q) alteration is located in exon 1 (coding exon 1) of the NRG3 gene. This alteration results from a G to A substitution at nucleotide position 488, causing the arginine (R) at amino acid position 163 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at